Lactose permease (LacY), a paradigm for the largest family of membrane transport proteins, catalyzes the coupled translocation of a galactoside and an H + across the Escherichia coli membrane (galactoside/H + symport). Initial X-ray structures reveal N-and C-terminal domains, each with six largely irregular transmembrane helices surrounding an aqueous cavity open to the cytoplasm. Recently, a structure with a narrow periplasmic opening and an occluded galactoside was obtained, confirming many observations and indicating that sugar binding involves induced fit. LacY catalyzes symport by an alternating access mechanism. Experimental findings garnered over 45 y indicate the following: (i) The limiting step for lactose/H + symport in the absence of the H + electrochemical gradient (Δμ̃H+) is deprotonation, whereas in the presence of Δμ̃H+, the limiting step is opening of apo LacY on the other side of the membrane; (ii) LacY must be protonated to bind galactoside (the pK for binding is ∼10.5); (iii) galactoside binding and dissociation, not Δμ̃H+, are the driving forces for alternating access; (iv) galactoside binding involves induced fit, causing transition to an occluded intermediate that undergoes alternating access; (v) galactoside dissociates, releasing the energy of binding; and (vi) Arg302 comes into proximity with protonated Glu325, causing deprotonation. Accumulation of galactoside against a concentration gradient does not involve a change in K d for sugar on either side of the membrane, but the pK a (the affinity for H + ) decreases markedly. Thus, transport is driven chemiosmotically but, contrary to expectation, ΔμH+ acts kinetically to control the rate of the process.
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X-ray crystal structure | membrane proteins | transport | conformational change | MFS The lactose permease of Escherichia coli (LacY) specifically binds and catalyzes symport of D-Gal and D-galactopyranosides with an H + (galactoside/H + symport), but it does not recognize the analogous glucopyranosides, which differ only in the orientation of the C4-OH of the pyranosyl ring (reviewed in refs. 1, 2). Typical of many major facilitator superfamily (MFS) members, LacY couples the free energy released from downhill translocation of H + in response to an H + electrochemical gradient (ΔμH+) to drive accumulation of galactopyranosides against a concentration gradient. Because coupling between sugar and H + translocation is obligatory, in the absence of Δμ̃H+, LacY can also transduce the energy released from the downhill transport of sugar to drive uphill H + transport with the generation of Δμ̃H+, the polarity of which depends upon the direction of the sugar gradient. However, the mechanism by which this so-called "chemiosmotic" process occurs remains obscure. This contribution aims at clarifying the specific steps underpinning the mechanism of galactoside/ H + symport.
Structural Evidence for an Occluded Intermediate
Initial X-ray structures of LacY were obtained with a conformationally restricted mutant C154G (3, 4) and WT LacY (5), and they are in an indistinguishable inward-facing conformation ( Fig. 1) . At the same time, a similar structure was determined for the glycerol-3-phosphate permease (6), which catalyzes phosphate/glycerol-3-phosphate exchange. The structures consist of two 6-helix bundles related by a quasi-twofold symmetry axis perpendicular to the membrane plane, linked by a long cytoplasmic loop between helices VI and VII. Furthermore, in each six-helix bundle, there are two 3-helix bundles with inverted symmetry. The two 6-helix bundles surround a deep hydrophilic cavity tightly sealed on the periplasmic face and open to the cytoplasmic side only (an inward-open conformation). The initial structures led to the "rocker-switch" model for transport in which the two 6-helix bundles rotate against each other around the middle of the protein, thereby exposing the substrate-binding site alternatively to either side of the membrane (also known as the alternating access model). Although LacY contains 65-70% unequivocally hydrophobic side chains and crystal structures reflect only a single lowest energy conformation, the entire backbone appears to be accessible to water (7) (8) (9) . In addition, an abundance of biochemical and spectroscopic data demonstrates that galactoside binding causes the molecule to open reciprocally on either side of the membrane, thereby providing almost unequivocal evidence for an alternating access model (discussed below). The first structure of LacY was obtained with a density at the apex of the central cavity, but because of limited resolution, the identity of the bound sugar and/or side-chain interactions was difficult to specify with certainty. However, biochemical and spectroscopic studies show that LacY contains a single galactoside-binding site and that the residues involved in sugar binding are located at or near the apex of the central, aqueous cavity in the approximate middle of the molecule.
Among the conserved residues in LacY and many other MFS members are two GlyGly pairs between the N-and C-terminal sixhelix bundles on the periplasmic side of LacY at the ends of helices II and XI (Gly46 and Gly370, respectively) and helices V and VIII (Gly159 and Gly262, respectively) (10). When Gly46 (helix II) and Gly262 (helix VIII) are replaced with bulky Trp residues (Fig. 2) , transport activity is abrogated with little or no effect on galactoside affinity, but markedly increased accessibility of galactoside to the binding site is observed, indicating that the G46W/G262W mutant is open on the periplasmic side (11) . Moreover, sitedirected alkylation and stopped-flow binding kinetics indicate that the G46W/G262W mutant is physically open on the periplasmic side (an outward-open conformation).
An X-ray structure of LacY mutant G46W/ G262W cocrystallized in the presence of the relatively high-affinity, symmetrical lactose analog β-D-galactopyranosyl-1-thio-β-Dgalactopyranoside (TDG) was determined Author contributions: H.R.K. designed research, analyzed data, and wrote the paper.
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at a resolution of 3.5 Å, and, importantly, crystals were not obtained in the absence of a galactoside (12) . Two molecules in the asymmetrical unit are adjacent to one another but in opposite-facing orientations. Surprisingly, both molecules are in an almost occluded conformation with a narrow periplasmic opening and a single molecule of TDG in the central sugar-binding site. A space-filling view of the molecule from the periplasmic side (Fig. 3A ) reveals the bound TDG through an opening that is too narrow to allow entrance or exit of the sugar (13) (∼3 Å at the narrowest point; Fig. 3B ). In contrast, the cytoplasmic side of the molecule is tightly sealed (Fig. 3C ). The double-Trp mutant is sufficiently open to bind galactoside rapidly (11) , but when binding occurs and the mutant attempts to transition into an occluded state, it cannot do so completely because the bulky Trp residues block complete closure. Thus, the mutant binds galactoside, which initiates transition into an intermediate occluded state that it cannot complete, and this finding probably accounts for why the mutant is completely unable to catalyze transport of any type across the membrane. It is also apparent that the transport cycle includes an occluded intermediate conformer.
A TDG molecule is clearly defined in the almost occluded central cavity (Fig. 4 ) that allows assignment of likely H-bond interactions with the protein, although interatomic distances are only estimates at a resolution of 3.5 Å. Specificity is directed toward the galactopyranoside ring, and α-galactosides bind with higher affinity than the β-anomers (14) (15) (16) (17) . One galactopyranosyl ring of TDG stacks hydrophobically with Trp151 (helix V), confirming biochemical (18) and spectroscopic (19) findings. Glu269 (helix VIII) is the acceptor of H bonds from the C4-OH and C3-OH groups of the galactopyranosyl ring, indicating that it is probably the primary determinant for specificity. Even conservative replacement with an Asp abolishes binding and inactivates lactose transport (20) (21) (22) . The η1 NH 2 of Arg144 (helix V) donates an H bond to O5 in the ring and is also within H-bond distance of the C6-OH. The η2 NH 2 group of Arg144 donates H bonds to the C2′-OH of TDG and to Glu126 Oe2. Conservative replacement of Arg144 with Lys, as well as neutral replacements, virtually destroys binding and transport (22, 23) . Glu126 (helix IV) acts as an H-bond acceptor from the C2′-OH of TDG and is an H-bond acceptor from the η2 NH 2 of Arg144. Replacement with Asp causes markedly diminished binding affinity, and removal of the carboxyl group abolishes binding and transport (21) (22) (23) .
Remarkably, His322 (helix X), long thought to be involved in H + transport by implication, likely acts as an H-bond donor/ acceptor between the eNH of the imidazole ring and the C3-OH of TDG, and it is stabilized by an H-bond donor/acceptor between the δΝΗ of the imidazole and the OH of Tyr236, which was also thought to be involved in H + transport (Fig. 5 ). All replacements for His322 exhibit little or no binding and no transport activity (22, 24, 25) . Finally, Asn272 (helix VIII) donates an H bond to the C4-OH of TDG; Gln is the only replacement tolerated by LacY with respect to binding and transport (26) .
In addition to the residues involved in galactoside binding, Cys148 (helix V), well known with respect to substrate protection against alkylation (reviewed in ref. 27) , is close to bound TDG, but not sufficiently close to interact directly (Fig. 5) . Similarly, replacement of Ala122 (helix IV) with bulky side chains or alkylation of A122C with bulky thiol reagents causes LacY to become specific for the monosaccharide Gal, and disaccharide binding and transport are blocked (28) . However, Ala122 does not make direct contact with TDG either. Asp240 (helix VII) and Lys319 (helix X) interact relatively weakly, and mutants with double-neutral replacements (Cys or Ala) exhibit low but significant ability to catalyze lactose accumulation (29) (30) (31) .
Although Glu325 (helix X) and Arg302 (helix IX) do not make direct contact with bound galactoside, both are critically involved in coupled H + translocation. Neutral replacement of either residue yields mutants that are defective in all transport reactions that involve net H + transport but catalyze equilibrium exchange and/or counterflow as well or better than WT (1, 2).
Sugar Binding Involves Induced Fit
In the structure of single-Cys122 LacY with covalently bound methanethiosulfonyl (MTS)-Gal, a suicide inactivator for this mutant (32), the galactosyl moiety occupies the same position in the protein as in the double-Trp mutant (33) . In addition, two important ligands, Trp151 and Glu269, interact with the galactopyranosyl ring (Fig. 6A) . However, as opposed to the almost occluded, open-outward conformation of the double-Trp mutant, LacY with covalently bound MTS-Gal in the binding site exhibits an inward-open conformation (Fig. 6B) , indicating that the galactoside must be fully liganded in order for LacY to transition into the occluded state. In view of this consideration and observations indicating that the alternating access mechanism of LacY is driven by galactoside binding and dissociation and not by ΔμH+ (1, 2, 34-36 ), it seems highly likely that sugar binding involves induced fit. By this means, the N-and C-terminal bundles converge as given side chains from both the N-and C-terminal helix bundles ligate the galactoside. The energetic cost of binding and the resultant conformational change are regained upon sugar dissociation and provide the energy for a further structural change that allows deprotonation. With respect to induced fit, it is also notable that mutation of any single binding-site residue causes a marked decrease or complete loss of affinity (22) . In brief, the mechanism of LacY resembles the mechanism of an enzyme, with the difference being that the protein, rather than the substrate, forms the transition state.
Seven Independent Lines of Support for the Alternating Access Model
As postulated, alternating access involves reciprocal access of galactoside-and H + -binding sites to either side of the membrane. Over the past few years, almost incontrovertible evidence for this structural mechanism has accrued with LacY (reviewed in refs. 37, 38): i) Because thiol cross-linking yields the closest distance between Cys residues, it was suggested that galactoside binding induces closure of the cytoplasmic cavity (3). ii) Site-directed alkylation of Cys replacements at every position in LacY shows that Cys replacements on the periplasmic side exhibit increased reactivity upon galactoside binding, whereas Cys replacements on the cytoplasmic side show decreased reactivity (39) (40) (41) (42) (43) (44) (53) . Therefore, LacY is protonated over the physiological range of pH (Fig. 7) . These observations and many others (1, 2) provide evidence for a symmetrical ordered kinetic mechanism in which protonation precedes galactoside binding on one side of the membrane and follows sugar dissociation on the other side (Fig. 8) . Recent observations (54) also suggest that a similar ordered mechanism may be common to other members of the MFS as well. Importantly, as mentioned above, mutants with neutral replacements for Glu325 catalyze equilibrium exchange and counterflow (the shaded reactions in Fig. 8 ) but do not catalyze any reaction involving net H + transport (55, 56) . Dramatically, the titration observed in Fig. 7 is abolished in mutant E325A and mutants with other neutral replacements for Glu325, which bind with high affinity up to pH 11, when LacY begins to denature. This behavior is highly unusual and suggests that Glu325 may be the sole residue directly involved in H + binding and transport [all 417 residues in LacY have been mutated and tested for transport activity (21) ]. Thus, LacY cannot sustain a negative charge on Glu325 and bind galactoside simultaneously, and Glu325 must be protonated to bind sugar.
However, deprotonation is also critical for turnover, and with an apparent pK of 10.5, how does deprotonation occur? One possibility is that the pK a of Glu325, which is in a hydrophobic pocket, may decrease by becoming more accessible to water. However, evidence has been presented indicating that Arg302 is important in this capacity (57, 58) . Like neutral replacements for Glu325, mutants R302A and R302S are also specifically defective in translocation reactions that involve H + translocation-accumulation of lactose against a concentration gradient, as well as efflux-but they bind ligand and catalyze equilibrium exchange. Perhaps the positively charged guanidium group at position 302 facilitates deprotonation of Glu325. Although Tyr236 lies between Arg302 and Glu325 in the current structure (Fig. 5) , double-mutant R302C/E325C exhibits excimer fluorescence when labeled with pyrene maleimide (59) and double-mutant R302H/E325H binds Mn(II) with micromolar affinity (60 . 1, 2) . It is also apparent that fully loaded LacY is not charged. Moreover, lactose/H + symport from a high-to lowlactose concentration in the absence of ΔμH+ exhibits a primary deuterium isotope effect that is not observed for ΔμH+-driven lactose/H + symport, equilibrium exchange, or counterflow (63, 64) . Thus, it is likely that the rate-limiting step for lactose/H + symport in the absence of Δμ̃H+ is deprotonation (65, 66) , whereas in the presence of Δμ̃H+, opening of apo LacY on the other side of the membrane is rate-limiting. In other words, by changing the rate-limiting step, Δμ̃H+ causes more rapid cycling. 6 for influx or effux, respectively), which is required for high-affinity binding of lactose. Sugar (S) binding to protonated LacY (step 2 or 5) causes a conformational change to an occluded state (step 3 or 4), which can relax to either side where sugar dissociates first (step 2 or 5), followed by deprotonation (step 1 or 6) and return of unloaded LacY via an apo occluded intermediate (steps 7 and 8). Exchange or counterflow involves only steps 2-5 (gray shaded area). Because LacY catalyzes symport in both directions, when symport is in the influx direction (step 1, protonation), the pK is very alkaline (∼10.5), and step 6 (deprotonation) must have a much lower pK for deprotonation to occur (i.e., Arg302 approximates protonated Glu325). However, in the efflux direction, the pKs of these steps are reversed.
Mechanism for Chemiosmotic Lactose
Taken as a whole, the observations suggest the following considerations regarding the mechanism of chemiosmotic coupling in LacY:
i) Symport in the absence or presence of ΔμH+ is the same overall reaction. The limiting step for lactose/H+ symport in the absence of ΔμH+ is deprotonation (a kinetic isotope effect is observed with D 2 O). The limiting step in the presence of a ΔμH+ is likely the conformational change associated with opening of the cavity on the other side of the membrane. ii) LacY must be protonated (possibly Glu325 specifically) to bind sugar (the pK for binding is ∼10.5 and is abolished in mutants with neutral replacements for Glu325).
iii) Sugar binding and dissociation, rather than ΔμH+, are the driving force for alternating access. iv) Sugar binding involves induced fit, causing a transition to an occluded intermediate that undergoes alternating access. v) Sugar dissociates, releasing the energy of binding. vi) A conformational change allows Arg302 to approximate protonated Glu325, resulting in deprotonation. vii) Apo LacY opens on the other side of the membrane, and the cycle is reinitiated.
Strikingly, accumulation of galactoside against a concentration gradient does not involve a change in K d for sugar on either side of the membrane, but the pK (the affinity for H + ) decreases markedly. Moreover, it is apparent that ΔμH+ does not have a direct effect on the global structural change that corresponds to alternating access. Thus, transport is driven chemiosmotically, and ΔμH+ acts kinetically to control the rate of the process. Finally, it should be relatively simple and straightforward to test the generality of this basic notion by determining whether or not an imposed Δμ̃H+ alters the rate of counterflow or equilibrium exchange with other members of the MFS.
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